Abstract
Background
Few studies have described the neuropsychological outcomes and frequency of structural brain or genetic abnormalities in adolescents with single ventricle who underwent the Fontan procedure.
Methods and Results
In a cross‐sectional, single‐center study, we enrolled 156 subjects with single ventricle, mean age 14.5±2.9 years, who had undergone the Fontan procedure. Scores in the entire cohort on a standard battery of neuropsychological tests were compared with those of normative populations or to those of a group of 111 locally recruited healthy adolescents. They also underwent brain magnetic resonance imaging and were evaluated by a clinical geneticist. Genetic abnormalities were definite in 16 subjects (10%) and possible in 49 subjects (31%). Mean Full‐Scale IQ was 91.6±16.8, mean Reading Composite score was 91.9±17.2, and mean Mathematics Composite score was 92.0±22.9, each significantly lower than the population means of 100±15. Mean scores on other neuropsychological tests were similarly lower than population norms. In multivariable models, risk factors for worse neuropsychological outcomes were longer total support and circulatory arrest duration at first operation, presence of a genetic abnormality, more operations and operative complications, more catheterization complications, and seizure history. The frequency of any abnormality on magnetic resonance imaging was 11 times higher among Fontan adolescents than referents (66% versus 6%); 19 (13%) patients had evidence of a stroke, previously undiagnosed in 7 patients (40%).
Conclusions
The neuropsychological deficits and high frequencies of structural brain abnormalities in adolescents who underwent the Fontan procedure highlight the need for research on interventions to improve the long‐term outcomes in this high‐risk group.
Keywords: congenital heart defects, Fontan procedure, genetics, magnetic resonance imaging
Subject Categories: Congenital Heart Disease, Cardiovascular Surgery, Imaging
Introduction
In recent decades, there has been improvement in both survival and neurodevelopment of children with single ventricle who have been palliated with use of the Fontan procedure. Nonetheless, these patients remain at increased risk of cognitive and behavioral impairments.1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 Although in some studies the deficits are modest in severity,12, 13 they are broad‐based and include reduced IQ scores, learning disorders, visuomotor integration deficits, attention deficit hyperactivity disorder (ADHD), and reduced quality of life.14, 15 The reported deficits have tended to be greater among patients with hypoplastic left heart syndrome (HLHS) than in those with other forms of univentricular heart,16, 17, 18 with occasional exceptions.19
Longitudinal studies of children with other forms of congenital heart disease (CHD) have shown that the full range of their neurodevelopmental morbidity can be appreciated only if follow‐up extends at least into adolescence, when patients face the complex academic and social challenges associated with this developmental epoch.20, 21 This period, with its greater demands for self‐regulation and self‐organization, may be particularly challenging for Fontan patients.
We report here on a cross‐sectional study of adolescents who underwent the Fontan procedure to palliate complex CHD. Neurodevelopmental outcomes and anatomic brain magnetic resonance imaging (MRI) at 10 to 19 years of age are compared with those of normative populations or those of a locally recruited healthy adolescent referent group. We hypothesized that patients whose first operation was a Norwood procedure versus another operation would have worse neurodevelopmental outcomes because of a greater likelihood of disturbed cerebral perfusion in utero and of neonatal open heart surgery. In addition, we report on operative, medical, and genetic risk factors for worse neurodevelopmental outcomes in these patients.
Methods
Subjects
We enrolled Fontan subjects from 2010 to 2012 at a single institution. Inclusion criteria were (1) age 10 to 19 years at the time of enrollment, (2) diagnosis of single ventricle lesion, and (3) history of Fontan procedure. We excluded patients who met any of the following criteria: (1) disorders that would prevent successful completion of the planned study testing (eg, pacemaker, metal implants preventing MRI); (2) lack of reading fluency by primary caregiver in English, which is the only language for which questionnaires have been validated; (3) foreign residence; (4) cardiac transplantation; and (5) cardiac surgery within 6 months of testing. The study was approved by the institutional review board, and we obtained informed consent of parent or guardian (for subjects aged <18 years) or of subjects (aged ≥18 years), as well as assent of study participants aged <18 years. A separate informed consent was obtained from parents to obtain their DNA.
We also recruited healthy referent subjects of a similar age from local pediatric practices, from our institutional adolescent clinic, and through posted notices. Because these subjects were recruited primarily for the purpose of comparing brain MRI, we applied exclusion criteria derived from the National Institutes of Health's MRI study of normal brain development.22 Data from these referent subjects were also used for comparison with Fontan subjects on psychometric tests for which normative data are not available.
Medical Data Obtained
By using medical record reviews, questionnaires, and family interviews, we recorded data on family history, events before the first operation, the number and types of cardiovascular interventions, intraoperative variables for all operations (eg, total support and circulatory arrest times), and major postoperative or postcatheterization complications (eg, cardiac arrest, need for extracorporeal membrane oxygenation, mediastinitis, necrotizing enterocolitis, prolonged intensive care unit course [>1 week], renal failure [serum creatinine >1.5 mg/dL], reoperation/exploration, seizure, stroke, and ventricular tachycardia). We also recorded concurrent comorbidities, including but not limited to ventricular and atrial arrhythmia, New York Heart Association (NYHA) functional class, thrombosis, stroke, seizure, protein‐losing enteropathy, cirrhosis, and plastic bronchitis. Subjects with single‐ventricle lesions were classified into those who had or had not undergone the Norwood procedure before the Fontan procedure.
Neuropsychological Assessment
The assessment battery included tests of general intelligence, academic achievement, memory, executive functions, visuospatial skills, attention, and social cognition. The specific assessments administered, and the scores derived from each, are described next.
General intelligence
The Wechsler Intelligence Scale for Children–Fourth Edition23 was administered to adolescents <17 years old, and the Wechsler Adult Intelligence Scale–Fourth Edition24 to adolescents 17 to 19 years of age. The end points considered were the 5 composite scores of Full‐Scale IQ, Verbal Comprehension, Perceptual Reasoning, Working Memory, and Processing Speed (all with an expected mean 100, SD 15).
Academic achievement
Each adolescent's Reading and Mathematics Composite scores (expected mean 100, SD 15 for both) of the Wechsler Individual Achievement Test–Second Edition25 were calculated. Tables provided in the Wechsler Intelligence Scale for Children–Fourth Edition Technical Manual were used to identify individuals for whom a Wechsler Individual Achievement Test–Second Edition score was significantly higher or lower than would be predicted based on the Full‐Scale IQ score.
Memory
For adolescents <17 years of age, scores on the core subtests (Dot Locations, Stories, Faces, and Word Pairs) of the Children's Memory Scale26 were combined to obtain the General Memory Index (expected mean 100, SD 15). For adolescents who were at least 17 years of age, the core subtests (Logical Memory, Verbal Paired Associates, Designs, and Visual Reproduction) and 2 additional subtests (Spatial Addition and Symbol Span) of the Wechsler Memory Scale–Fourth Edition27 were administered. Scores were combined to calculate an overall memory score (expected mean 100, SD 15).
Executive functions
An executive function summary score was calculated by averaging an adolescent's scores on 5 subtests of the Delis–Kaplan Executive Function System28: Verbal Fluency (mean score on the letter and semantic fluency trials), Design Fluency (primary combined measure), Sorting (combined conditions score), Word Context (consecutively correct score), and Tower (total achievement score). The expected mean score is 10. Three informants (parent, teacher, self) completed the Behavior Rating Inventory of Executive Function (BRIEF).29, 30 For each informant, the General Executive Composite score was analyzed. The expected mean score is 50 (SD 10), with a higher score indicating less optimal function.
Visuospatial skills
A visuospatial composite score was calculated by averaging an adolescent's scores on 3 subscales (Memory, Sequential Memory, and Closure) of the Test of Visual‐Perceptual Skills (nonmotor) (Upper Level)–Revised.31 The expected mean score is 100 (SD 15). In addition, the copy and immediate recall trials of the Rey–Osterrieth Complex Figure were administered to each adolescent. For each trial, an overall Organization score and scores for Structural Elements and Incidental Elements were derived by using the Developmental Scoring System.32 Each adolescent also completed the Sense of Direction Scale, which assesses environmental spatial ability.33
Attention
The ADHD Index T score yielded by the parent‐completed Conners’ ADHD/Diagnostic and Statistical Manual of Mental Disorders–Fourth Edition34 served as the primary measure of attention. The expected mean is 50 (SD 10), with higher scores indicating greater attention problems.
Social cognition
Three assessments of social cognition were administered. The Reading the Mind in the Eyes Test–Revised35 indicates skill at identifying others’ emotional states (higher score is better). The Toronto Alexithymia Scale36 assesses the ability to identify and label one's own emotions. A total score is calculated from 3 subscales: Difficulty Identifying Feelings, Difficulty Describing Feelings, and Externally‐Oriented Thinking. Higher scores suggest greater difficulties. The Autism Spectrum Quotient37 indicates autistic tendencies (higher score is worse, ie, greater autistic tendencies).
Magnetic Resonance Imaging
MRI was performed on 1 of 2 systems: a 3‐T General Electric system (General Electric Medical Systems) or, for patients in whom cardiovascular devices or coils had been implanted, a 1.5‐T General Electric Twinspeed magnetic resonance scanner. MRI methods using the 1.5‐T scanner have previously been described.20, 21 Subjects were scanned without the use of sedation. The T1‐weighted acquisition used a 3‐dimensional spoiled gradient recalled steady state sequence with the following parameters: repetition time/echo time=7/2.8 ms; flip angle=8°; and voxel size=1 mm3 isotropic. The susceptibility sensitive T2‐weighted acquisition consisted of multiplanar gradient recalled axial sequences with repetition time/echo time=600/40 ms; flip angle=30°; slice thickness=5 mm (with 1‐mm gap); and voxel size=0.8594×0.8594×6 mm3 chosen to maintain a streamlined total scan time.
Brain MRI results were read by a single blinded neuroradiologist (R.L.R.). Images were assessed by visual inspection to rate the quality of data and to identify abnormalities. Abnormalities were classified by origin (acquired or developmental), type (infarction, mineralization, iron deposition, myelination delay, ventriculomegaly, or abnormal T2‐weighted signal hyperintensity), extent (focal or diffuse), and anatomic location.
Genetics Evaluation
Genetics evaluation of the Fontan patients included examination by a clinical geneticist (A.E.R.), medical record review, and blood sampling for a chromosomal microarray, performed on an oligonucleotide‐based Agilent 244k platform array that detected deletions or duplications at multiple targeted sites throughout the genome. It contained probes to detect copy number changes as small as 150 kb between the target regions. We classified subjects as having a possible or definite genetic abnormality if they met ≥1 of the following criteria: a relevant known genetic diagnosis at time of enrollment, a pathogenic variant on array, a variant of unknown significance on array, and/or syndromic presentation (defined as dysmorphic features and/or extracardiac birth defects).
Statistical Methods
Comparisons of operative and medical risk factors, special services, and MRI findings were performed by using Fisher's exact tests for categorical measures and either ANOVA for continuous measures (when normally distributed) or Kruskal–Wallis tests (when non‐normal). Comparisons of NYHA functional class were made with Cochran–Armitage trend tests. Neuropsychological outcomes of Fontan adolescents, collectively and stratified by Norwood procedure, were compared with available expected population means by using 1‐sample t tests. Linear regression with adjustment for concurrent family social status (ie, Hollingshead Four‐Factor Index of Social Status) was used to compare neuropsychological outcomes of Fontan adolescents with those of the referent group when a population mean was not available (ie, Rey–Osterrieth Complex Figure, Sense of Direction Scale, Reading the Mind in the Eyes Test–Revised, Toronto Alexithymia Scale, Autism Spectrum Quotient), as well as for comparisons between Norwood groups.
We used linear regression analyses to identify earlier risk factors for neuropsychological outcomes in Fontan adolescents among the predictors listed in Table 1 (except cardiac diagnosis, continuous age at operation, indicator for use of deep hypothermic circulatory arrest at first operation, NYHA functional class, and use of special services) after adjusting for family social status and Norwood procedure. We did not adjust for the large number of types of anatomic heart disease because, with the exception of HLHS, the number of patients in each category was small, and the type of heart lesion and surgical variables were collinear. For closed procedures, values of deep hypothermic circulatory arrest and total support duration were set to 0. Predictors associated with neuropsychological outcomes at a level of P<0.20 were considered for stepwise backward regression, for which P<0.05 served as the significance criterion while adjusting for family social status and Norwood procedure. A similar procedure was used to identify factors predicting MRI outcomes by using logistic regression while adjusting for genetic abnormality.
Table 1.
Variable | All (N=156) | Norwood (n=63) | Non‐Norwood (n=93) | P Value |
---|---|---|---|---|
Percent, Mean±SD, or Median (IQR) | ||||
Preoperative characteristics | ||||
Birth weight, kg | 3.3±0.6 | 3.4±0.6 | 3.2±0.7 | 0.09 |
Gestational age, wk | 38.9±2.2 | 39.2±2.0 | 38.8±2.4 | 0.27 |
Male | 61 | 67 | 57 | 0.25 |
Race | 0.15 | |||
Asian | 3 | 0 | 4 | |
Black | 4 | 6 | 3 | |
White | 93 | 94 | 92 | |
Hispanic ethnicity | 12 | 10 | 14 | 0.46 |
Cardiac diagnosis | <0.001 | |||
HLHS | 26 | 65 | 0 | |
Tricuspid atresia | 19 | 14 | 23 | |
DORV | 12 | 6 | 16 | |
DILV | 12 | 13 | 11 | |
Heterotaxy syndrome | 11 | 2 | 17 | |
Complex TGA | 8 | 0 | 13 | |
PA/IVS | 6 | 0 | 11 | |
Unbalanced AV canal | 3 | 0 | 4 | |
Mitral atresia | 1 | 0 | 2 | |
Other | 2 | 0 | 3 | |
Genetic abnormality | 42 | 30 | 49 | 0.02 |
Status at first operation | ||||
Age, d | 6 (3–22) | 5 (3–8) | 7 (3–87) | 0.01 |
Neonatal status, age ≤30 d | 78 | 95 | 67 | <0.001 |
Open procedure | 59 | 100 | 31 | <0.001 |
Patients undergoing DHCA (if open) | 71 | 91 | 15 | <0.001 |
DHCA duration, min (if open) | 42 (0–56) | 49 (33–58) | 0 (0–0) | <0.001 |
Total support duration, min (if open) | 121 (99–141) | 125 (115–150) | 81 (66–107) | <0.001 |
No. of operative complications | <0.001 | |||
0 | 43 | 17 | 61 | |
1 | 22 | 22 | 22 | |
≥2 | 35 | 60 | 16 | |
Medical history | ||||
Total No. of operations | <0.001 | |||
1 or 2 | 18 | 3 | 28 | |
3 | 64 | 84 | 51 | |
4 or 5 | 18 | 13 | 22 | |
Total No. of open operations | <0.001 | |||
1 | 9 | 0 | 15 | |
2 | 39 | 3 | 63 | |
≥3 | 52 | 97 | 22 | |
Total No. of operative complications | <0.001 | |||
0 | 15 | 5 | 23 | |
1 to 5 | 67 | 67 | 68 | |
≥6 | 17 | 29 | 10 | |
Total No. of catheterizations | 0.56 | |||
1 or 2 | 11 | 14 | 9 | |
3 to 5 | 69 | 67 | 70 | |
≥6 | 21 | 19 | 22 | |
Total No. of catheterization complications | 0.97 | |||
0 | 49 | 51 | 48 | |
1 or 2 | 40 | 40 | 41 | |
≥3 | 10 | 10 | 11 | |
New York Heart Association functional class | 0.16 | |||
I | 29 | 25 | 31 | |
II | 63 | 62 | 63 | |
III | 8 | 13 | 5 | |
Seizure | 15 | 24 | 9 | 0.01 |
Any neurological eventa | 25 | 31 | 22 | 0.26 |
Use of special services | 86 | 90 | 83 | 0.24 |
Tutoring | 56 | 65 | 49 | 0.07 |
Grade retention | 23 | 21 | 25 | 0.70 |
Early intervention | 57 | 60 | 55 | 0.51 |
Occupational therapy | 54 | 62 | 48 | 0.10 |
Physical therapy | 51 | 62 | 44 | 0.03 |
Special education | 35 | 44 | 29 | 0.06 |
Psychotherapy and counseling | 45 | 49 | 42 | 0.41 |
Family social statusb | 50±13 | 48±13 | 51±13 | 0.09 |
Age at developmental testing, y | 14.5±2.9 | 14.1±2.8 | 14.7±3.1 | 0.22 |
Values are represented as percentages, mean±SD, or median (IQR). P values are determined by Fisher's exact tests for categorical variables (except for New York Heart Association class, which used a Cochran–Armitage trend test), analysis of variance for variables with means reported, and Kruskal–Wallis tests for variables with medians reported. AV indicates atrioventricular; DHCA, deep hypothermic circulatory arrest; DILV, double inlet left ventricle; DORV, double outlet right ventricle; HLHS, hypoplastic left heart syndrome; PA/IVS, pulmonary atresia with intact ventricular septum; TGA, transposition of the great arteries.
Includes stroke, seizure, choreoathetosis, and meningitis.
Score on Hollingshead Four Factor Index of Social Status, with higher scores indicating higher social status.
Results
Cardiac Status and History
Among 362 Fontan adolescents who met the eligibility criteria, 116 (32%) were followed at other institutions or lost to follow‐up. Of the 246 invited to participate, 90 (35%) declined to participate. Patients who consented versus declined did not differ in sex, race, or diagnosis of HLHS. Our study cohort consisted of the remaining 156 adolescents, as well as 111 referent subjects. Table 1 summarizes the medical histories of the Fontan adolescents. Most (64%) had undergone staged palliation, with a median of 3 operations (range 1–5), and 40% had HLHS or another single right ventricle anomaly requiring the Norwood procedure.
Compared with referent subjects, Fontan subjects had lower birth weight (3.3±0.6 versus 3.5±0.6 kg, P=0.01), were of younger gestational age (38.9±2.2 versus 39.6±1.3 weeks, P=0.007), were more likely to be white (93% versus 83%, P=0.03), had lower concurrent family social status (50±13 versus 53±10, P=0.02), and were significantly younger at developmental testing (14.5±2.9 versus 15.3±1.8 years, P=0.008), but they had similar distributions of sex and ethnicity. Fontan adolescents who underwent the Norwood procedure, compared with those who did not, were less likely to have genetic abnormalities (P=0.02), were more likely to have had neonatal heart surgery (P<0.001), were more likely to have had a first operation that was performed on bypass (P<0.001), had longer deep hypothermic circulatory arrest and total support durations at first operation (P<0.001 each), and had more operative complications (P<0.001).
Most Fontan adolescents were in NYHA functional class II (63%), while 29% were in class I, and 8% were in class III. None were in class IV. In contrast, most referent subjects were in NYHA functional class I (95%), with the remaining 5% in class II (P<0.001). NYHA functional class did not differ between Fontan patients who had undergone the Norwood procedure versus those who had not.
Among Fontan adolescents, medical histories included seizures (n=23, 15%), stroke (n=19, 12%), choreoathetosis (n=1, 1%), and meningitis (n=1, 1%). Parents reported that 22% (n=34) had been diagnosed with ADHD and 37% (n=57) with a learning disability. Medications in the Fontan group included therapies for attention‐deficit disorder or ADHD (n=15, 10%) and psychotropic agents (n=13, 8%). Three Fontan adolescents (2%) reported use of both ADHD and psychotropic medications.
Genetics Evaluation
Of 156 enrolled subjects, 6 had a genetic diagnosis at the time of enrollment (22q11 deletion, CHARGE syndrome [represents coloboma, heart defect, atresia choanae (also known as choanal atresia), retarded growth and development, genital abnormality, and ear abnormality], hyperphenylalaninemia, Kartagener syndrome, and 2 cases of VACTERL [vertebral defects, anal atresia, cardiac defects, tracheoesophageal fistula, renal anomalies, and limb abnormalities]), and 134 had a physical examination completed by a medical geneticist (A.E.R.) and array comparative genomic hybridization (CGH) analysis. Ten percent were classified as having a definite genetic abnormality (6 subjects with a genetic diagnosis at the time of enrollment and 10 subjects with a pathogenic variant on array CGH). An additional 31% were classified as having a possible genetic abnormality (17 with a variant of unknown significance on array CGH and 32 with normal array but syndromic features). The Norwood and non‐Norwood groups did not differ significantly with respect to genetic diagnosis at the time of enrollment or abnormal array CGH. However, the Norwood group was less likely to have syndromic features than were the non‐Norwood group (18% versus 42%, P=0.003).
On array CGH, 7 Fontan subjects had 2 abnormalities, 2 subjects had 3 abnormalities, and 1 subject had 4 abnormalities, for a total of 55 variants in 41 probands (Table 2). Of the variants, 25% were judged to be pathogenic (3 syndromic subjects and 7 nonsyndromic subjects); 44% were variants of unknown significance (7 syndromic subjects and 12 nonsyndromic subjects); and 31% were thought to be likely benign (5 syndromic subjects and 12 nonsyndromic subjects). The overall rate of pathogenic copy number variant (CNV) detection was 7% (10/134). Of the pathogenic variants, 7 were thought to explain the CHD (3 cases of hypoplastic right ventricle, 3 cases of hypoplastic left ventricle, and 1 case of tricuspid atresia). The remaining 3 CNVs were clinically significant for extracardiac anomalies but without a clear association to CHD based on the published literature and what is known biologically about the genes in the region. The syndromic and nonsyndromic groups did not differ significantly in their prevalence of CNVs (any type) or pathogenic CNVs. There were 20 deletions reported, none recurrent, ranging in size from 19 kb to 4.6 Mb. There were 31 duplications reported, none recurrent, ranging in size from 12 kb to 2.2 Mb.
Table 2.
Proband | Cardiac Diagnosis | Array Result | Size | Syndromic |
---|---|---|---|---|
Variant known to be pathogenic for congenital heart disease (7 probands, 11 variants) | ||||
1a | PA/IVS | 2p16.2‐p14 LOH | 12.6 Mb | Y |
1b | 5q14.1‐q22.1 LOH | 30.2 Mb | ||
1c | 12p13.1‐p12.1 LOH | 11.3 Mb | ||
1d | 13q12.13‐q13.3 LOH | 9.8 Mb | ||
2a | DILV | 4q35.1q35.2 del | 4.6 Mb | N |
2b | 4q35.1 dup | 509 kb | ||
3 | HLHS | 2q13 dup | 2.2 Mb | N |
4 | PA/IVS | 3q28 del | 313 kb | N |
5a | HLHS | 7q36.3 del | 2.4 Mb | N |
6a | Tricuspid atresia | 9q31.2 dup | 219 kb | Y |
7 | HLHS | 15q11.2 del | 257 kb | N |
Variant known to be pathogenic for extracardiac disease (3 probands) | ||||
8 | Complex TGA | 15q13.2‐q13.3 dup | 1.5 Mb | N |
9a | Complex TGA | 16p11.2 del | 220 kb | Y |
10a | HLHS | 17p13.2 del | 76 kb | N |
Benign variant (inherited, no family history of congenital heart disease; 17 probands) | ||||
11 | DORV | 2p16.3 dup | 75 kb | N |
12 | HLHS | 2p24.3 del | 210 kb | N |
5b | HLHS | 3p11.1 dup | 983 kb | N |
13 | Tricuspid atresia | 6q21 dup | 438 kb | Y |
14 | Heterotaxy syndrome | 8p22 dup | 249 kb | Y |
15 | PA/IVS | 8q24.21 dup | 274 kb | Y |
6b | Tricuspid atresia | 9q33.1 dup | 672 kb | Y |
16 | HLHS | 10q21.3 dup | 1.9 Mb | N |
17 | Tricuspid atresia | 10q24.2 del | 251 kb | N |
18 | DILV | 14q11.2 dup | 12 kb | N |
10b | HLHS | 15q15.3 del | 248 kb | N |
19 | HLHS | 15q21.2 dup | 308 kb | Y |
20 | Tricuspid atresia | 16p13.2 dup | 159 kb | N |
21 | HLHS | 16p13.3 del | 265 kb | N |
22 | HLHS | 20p11.23 dup | 453 kb | N |
22sib | HLHS | 20p11.23 dup | 453 kb | N |
23 | HLHS | Xp11.4 dup | 191 kb | N |
24 | HLHS | Xq21.1 dup | 105 kb | N |
Variant of unknown significance (19 probands. 24 variants) | ||||
25a | DORV | 6q26 dup | 98 kb | Y |
25b | Yq11.21 dup | 126 kb | ||
25c | Yq11.21 dup | 290 kb | ||
26a | DORV | 1q21.3 dup | 728 kb | N |
26b | 11p11.2 del | 19 kb | ||
27a | Complex TGA | 2p22.1 dup | 361 kb | N |
27b | 7q36.3 dup | 323 kb | ||
28a | Heterotaxy syndrome | 11q14.1‐q14.2 del | 1.2 Mb | Y |
28b | 22q13.2 | 52 kb | ||
29 | Tricuspid atresia | 1q42.2 dup | 89 kb | N |
30 | Heterotaxy syndrome | 2q31.2 dup | 627 kb | Y |
31 | DORV | 3p21.31 dup | 251 kb | Y |
32 | Tricuspid atresia | 3p26.1 dup | 68 kb | N |
9b | Complex TGA | 4p15.2 del | 375 kb | Y |
33 | Mitral atresia | 6q24.3 del | 58 kb | N |
34 | HLHS | 7p14.1 dup | 271 kb | N |
35 | HLHS | 8q22.1 del | 412 kb | N |
36 | HLHS | 10q26.2 del | 127 kb | N |
37 | Heterotaxy syndrome | 15q23 dup | 276 kb | Y |
38 | Mitral atresia | 15q25.2 del | 105 kb | N |
39 | Tricuspid atresia | 18p11.31 dup | 421 kb | N |
40 | DILV | 18p11.32‐p11.31 del | 3.7 Mb | Y |
2c | DILV | 21q22.11 dup | 112 kb | N |
41 | Tricuspid atresia | Xp22.31 dup | 1.6 Mb | N |
DILV indicates double inlet left ventricle; DORV, double outlet right ventricle; HLHS, hypoplastic left heart syndrome; LOH, loss of heterozygosity; PA/IVS pulmonary atresia with intact ventricular septum; TGA, transposition of the great arteries.
Compared with Fontan adolescents without genetic abnormalities, those with definite or possible genetic abnormalities were more likely to have received special services, including early intervention, occupational therapy, physical therapy, special education, and psychotherapy or counseling (data not shown). Because we grouped those with definite and possible genetic abnormalities together in the “genetic abnormality group,” our analysis may underestimate the effect of a genetic diagnosis on neuropsychological outcomes.
Neuropsychological Assessment
Table 3 presents the neuropsychological scores of all Fontan adolescents, collectively and stratified by Norwood procedure, along with the results of comparisons with the expected population mean scores and the scores of the referent group. Table 4 presents the percentages of adolescents in the Norwood and non‐Norwood groups with neuropsychological scores that were >1 or >2 SDs below the expected mean and parent or teacher ratings of executive function that were in the range considered to be clinically significant. As the tables illustrate, the scores of the Fontan group as a whole on most tests were significantly worse than the expected population means or the scores of the referent group. Therefore, the following section focuses on comparisons of the scores of the Norwood and non‐Norwood groups.
Table 3.
Variable | All (N=156) | Norwood (n=63) | Non‐Norwood (n=93) | P Value, All Fontan Versus Referenta | P Value, Norwood Versus Non‐Norwooda | P Value, Norwood Versus Expected Population Meanb | P Value, Non‐Norwood Versus Expected Population Meanb |
---|---|---|---|---|---|---|---|
Mean±SD | |||||||
Wechsler Intelligence Scales, Combined | |||||||
Full‐Scale IQ | 91.6±16.8 | 86.0±17.6 | 95.5±15.2 | <0.001 | 0.001 | <0.001 | 0.005 |
Verbal Comprehension | 97.6±15.4 | 91.1±15.7 | 101.9±13.6 | <0.001 | <0.001 | <0.001 | 0.17 |
Perceptual Reasoning | 92.6±16.3 | 88.6±17.4 | 95.3±15.1 | <0.001 | 0.02 | <0.001 | 0.004 |
Working Memory | 92.7±15.8 | 89.8±15.9 | 94.7±15.5 | <0.001 | 0.12 | <0.001 | 0.001 |
Processing Speed | 87.4±16.4 | 83.0±16.7 | 90.4±15.5 | <0.001 | 0.009 | <0.001 | <0.001 |
Wechsler Individual Achievement Test | |||||||
Reading Composite | 91.9±17.2 | 87.3±18.0 | 95.0±16.1 | <0.001 | 0.02 | <0.001 | 0.004 |
Mathematics Composite | 92.0±22.9 | 85.8±22.9 | 96.1±22.1 | <0.001 | 0.02 | <0.001 | 0.09 |
Children's Memory Scale General Memory Indexc | 93.9±21.5 | 89.3±23.4 | 97.3±19.3 | 0.001 | 0.10 | 0.002 | 0.25 |
Wechsler Memory Scale Composited | 87.4±16.1 | 80.7±17.6 | 90.3±14.8 | <0.001 | 0.09 | 0.005 | 0.003 |
Executive Function Summary Score | 8.6±2.2 | 8.1±2.3 | 8.9±2.1 | <0.001 | 0.0499 | <0.001 | <0.001 |
Behavior Rating Inventory of Executive Function | |||||||
Parent | 57.6±12.1 | 58.7±11.8 | 56.8±12.3 | <0.001 | 0.46 | <0.001 | <0.001 |
Teacher | 60.9±16.0 | 63.6±16.1 | 58.9±15.8 | 0.003 | 0.17 | <0.001 | <0.001 |
Self‐reporte | 49.9±11.4 | 51.1±11.9 | 49.2±11.1 | <0.001 | 0.48 | 0.53 | 0.53 |
Test of Visual‐Perceptual Skills Compositef | 85.2±17.9 | 81.9±18.3 | 87.5±17.4 | <0.001 | 0.20 | <0.001 | <0.001 |
Rey–Osterrieth Complex Figureg | |||||||
Copy: Organization | 6.7±3.3 | 5.8±3.0 | 7.4±3.4 | <0.001 | 0.007 | <0.001 | <0.001 |
Structural Element | 24.0±2.4 | 23.2±3.5 | 24.6±1.1 | <0.001 | 0.001 | <0.001 | 0.01 |
Incidental Element | 37.2±3.6 | 36.2±4.5 | 37.8±2.7 | <0.001 | 0.006 | <0.001 | <0.001 |
Immediate Recall: Organization | 5.6±3.5 | 4.5±3.3 | 6.4±3.5 | <0.001 | 0.003 | <0.001 | <0.001 |
Structural Element | 19.3±5.4 | 17.5±6.4 | 20.5±4.3 | <0.001 | 0.001 | <0.001 | <0.001 |
Incidental Element | 24.6±8.5 | 22.1±8.8 | 26.2±8.0 | <0.001 | 0.002 | <0.001 | 0.004 |
Sense of Direction Scaleg | 44.6±10.7 | 43.6±11.4 | 45.3±10.2 | 0.002 | 0.29 | 0.003 | 0.02 |
Parent Conners’ ADHD Index T Score | 60.0±13.4 | 61.6±13.7 | 58.9±13.2 | <0.001 | 0.34 | <0.001 | <0.001 |
Reading the Mind in the Eyes Test Scoreg | 18.6±5.9 | 16.9±5.8 | 19.6±5.8 | <0.001 | 0.02 | <0.001 | <0.001 |
Toronto Alexithymia Scale Total Scoreg | 50.8±10.9 | 52.2±12.2 | 50.0±10.0 | 0.02 | 0.24 | 0.04 | 0.07 |
Autism Spectrum Quotientg | 17.5±5.2 | 18.8±5.7 | 16.7±4.6 | <0.001 | 0.03 | <0.001 | 0.02 |
Values are mean±SD. Missing <10% of outcomes except for Behavior Rating Inventory of Executive Function–Teacher (Fontan: n=90; referent: n=42), Test of Visual‐Perceptual Skills (Fontan: n=93; referent: n=96), Reading the Mind in the Eyes (Fontan: n=140; referent: n=98), and the Toronto Alexithymia Scale (referent: n=66) tasks. ADHD indicates attention‐deficit/hyperactivity disorder.
P values are determined by linear regression with adjustment for concurrent family social status.
P values are determined by 1‐sample t tests comparing the Fontan group with expected population means of 100, 10, or 50, as appropriate.
Outcomes are based on those Fontan subjects (n=120) and referents (n=97) aged <17 years.
Outcomes are based on those Fontan subjects (n=36) and referents (n=14) aged ≥17 years.
Outcomes are based on those Fontan subjects (n=134) and referents (n=109) aged ≥11 years.
Outcomes are based on those Fontan subjects (n=119) and referents (n=105) aged ≥12 years.
Expected population means are not available; P values are determined by linear regression comparing the Fontan group and the referent group with adjustment for concurrent family social status.
Table 4.
Variable | All (N=156) | Norwood (n=63) | Non‐Norwood (n=93) | P Value, Norwood Versus Non‐Norwooda |
---|---|---|---|---|
% | ||||
Wechsler Intelligence Scales, Combined: Full‐Scale IQ | ||||
≤85 | 31 | 43 | 24 | 0.01 |
≤70 | 12 | 17 | 8 | 0.07 |
Wechsler Individual Achievement Test | ||||
Reading Composite | ||||
≤85 | 29 | 42 | 20 | 0.006 |
≤70 | 12 | 18 | 8 | 0.07 |
Mathematics Composite | ||||
≤85 | 35 | 47 | 27 | 0.02 |
≤70 | 19 | 23 | 17 | 0.41 |
Children's Memory Scale General Memory Indexb | ||||
≤85 | 34 | 41 | 28 | 0.17 |
≤70 | 18 | 25 | 12 | 0.09 |
Wechsler Memory Scale Compositec | ||||
≤85 | 39 | 64 | 28 | 0.07 |
≤70 | 14 | 27 | 8 | 0.15 |
Executive Function Summary Score | ||||
≤7 | 23 | 35 | 14 | 0.003 |
≤4 | 5 | 5 | 4 | 1.0 |
Behavior Rating Inventory of Executive Function | ||||
Parent, ≥65 | 33 | 35 | 32 | 0.73 |
Teacher, ≥65 | 34 | 44 | 27 | 0.12 |
Self‐Report, ≥65 | 11 | 12 | 10 | 1.0 |
Parent Conners’ ADHD Index T Score, >65 | 33 | 40 | 29 | 0.16 |
Values are percentages. Missing <10% of outcomes except for Behavior Rating Inventory of Executive Function–Teacher (n=90) task. ADHD indicates attention‐deficit/hyperactivity disorder.
P values are determined by Fisher's exact tests.
Outcomes are based on those Fontan subjects (n=120) aged <17 years.
Outcomes are based on those Fontan subjects (n=36) aged ≥17 years.
General Intelligence
The Norwood group scored lower than the non‐Norwood group on all composites except Working Memory. More than 2 (43%) in 5 of the Norwood group had a Full‐Scale IQ score ≤85 (compared with an expected frequency in the general population of 16%) and 17% scored ≤70 (compared with the expected 2%). One (24%) in 4 adolescents in the non‐Norwood group had a Full‐Scale IQ score ≤85 and 8% scored ≤70.
Academic Achievement
Reading and Mathematics Composite scores were significantly lower for the Norwood group than for the non‐Norwood group (P=0.02 for both). Among the Norwood adolescents, 42% scored ≤85 and 18% scored ≤70 on the Reading Composite. On the Mathematics Composite, 47% scored ≤85 and 23% scored ≤70. For nearly one‐third (31%) of those who had undergone the Norwood procedure as neonates, the Reading Composite score was significantly lower than would be expected based on the Full‐Scale IQ score, while the corresponding figure for the Mathematics Composite score was 39%. One (20%) in 5 adolescents in the non‐Norwood group scored ≤85 on the Reading Composite and 8% scored ≤70. The corresponding figures for Mathematics Composite scores were 27% and 17%, respectively. On the Reading Composite, 26% scored significantly lower than expected based on Full‐Scale IQ, and 31% scored significantly lower than expected on the Mathematics Composite.
Memory
The overall mean scores of adolescents in the Norwood and non‐Norwood groups did not differ significantly, though the mean scores of the Norwood group were ≈0.5 SD lower for both age groups. In the Norwood group on the Children's Memory Scale, ≈2 (41%) in 5 scored ≤85 and 25% scored ≤70, while in the non‐Norwood group, 28% scored ≤85 and 12% scored ≤70. On the Wechsler Memory Scale, 64% of the Norwood group scored ≤85 and 27% scored ≤70, while in the Norwood group, 28% scored ≤85 and 8% scored ≤70.
Executive Functions
The mean executive function summary score of the Norwood group was lower than the mean score of the non‐Norwood group (P<0.05). In the Norwood group, 35% scored ≥3 points below 10 (ie, ≈>1 SD), and 5% scored ≥6 points below 10 (ie, ≈>2 SDs). In the non‐Norwood group, 14% scored ≥3 points below the expected mean and 4% scored ≥6 points below the expected mean. On the BRIEF, the mean General Executive Composite scores of the Norwood and non‐Norwood groups did not differ significantly for any of the 3 informants, though the scores of the Norwood group tended to be somewhat higher. On the parent BRIEF, 35% of the Norwood group scored ≥65 (ie, “potential clinical significance”), compared with 32% of the non‐Norwood group. On the teacher BRIEF, these figures were 44% and 27%, respectively, and on the self‐report BRIEF, they were 12% and 10%, respectively.
Visuospatial Skills
The scores of the Norwood and non‐Norwood groups did not differ significantly for the Test of Visual‐Perceptual Skills summary or the Sense of Direction Scale, but the Norwood group did score lower on all scales of both the copy and immediate recall trials of the Rey–Osterrieth Complex Figure (P=0.001 to 0.007).
Attention
Although the mean score of the Norwood group was higher than that of the non‐Norwood group, the difference was not significant. Approximately 2 (40%) in 5 of adolescents in the Norwood group and 29% of adolescents in the non‐Norwood group scored ≥66, which is considered to be “moderately atypical.”
Social Cognition
The scores of the Norwood and non‐Norwood groups did not differ significantly on the Toronto Alexithymia Scale (total score), but the Norwood group did score significantly worse on the Reading the Mind in the Eyes Test–Revised (P=0.02) and the Autism Spectrum Quotient (P=0.03).
MRI Data
MRI data were available for 144 adolescents who underwent the Fontan procedure and 105 referents. The frequency of any abnormality was 11‐fold greater among the patients than the referents (66% versus 6%, P<0.001; Table 5). The majority of abnormalities were focal or multifocal, with most involving brain mineralization or iron deposits, and 19 (13%) patients had evidence of a stroke. Among these, stroke had been previously diagnosed in only 12 patients (60%). Diffuse abnormalities were also more common in the Fontan group (9% versus 2%, P=0.03), with the majority consisting of abnormal T2‐weighted hyperintensities. The Norwood and non‐Norwood groups did not differ in the frequency of MRI abnormalities.
Table 5.
Variable | Fontan | |||||
---|---|---|---|---|---|---|
All (n=144) | Norwood (n=59) | Non‐Norwood (n=85) | Referent (n=105) | P Value, All Fontan Versus Referent | P Value, Norwood Versus Non‐Norwood | |
n/Total N (%) | ||||||
Any abnormality | 69/105 (66) | 30/42 (71) | 39/63 (62) | 6/94 (6) | <0.001 | 0.40 |
Focal or multifocal abnormality | 64/106 (60) | 27/42 (64) | 37/64 (58) | 1/94 (1) | <0.001 | 0.55 |
Focal infarction or atrophy | 19/144 (13) | 7/59 (12) | 12/85 (14) | 0/105 (0) | <0.001 | 0.80 |
Brain mineralization/iron deposit | 57/106 (54) | 23/42 (55) | 34/64 (53) | 1/94 (1) | <0.001 | 1.0 |
Diffuse abnormality | 12/133 (9) | 6/53 (11) | 6/80 (8) | 2/104 (2) | 0.03 | 0.54 |
Myelination delay | 0/144 (0) | 0/59 (0) | 0/85 (0) | 0/104 (0) | — | — |
Ventriculomegaly | 3/144 (2) | 1/59 (2) | 2/85 (2) | 0/104 (0) | 0.27 | 1.0 |
Abnormal T2 hyperintensities | 9/133 (7) | 5/53 (9) | 4/80 (5) | 2/105 (2) | 0.12 | 0.48 |
Generalized abnormality | 0/144 (0) | 0/59 (0) | 0/85 (0) | 0/104 (0) | — | — |
Developmental abnormality | 6/144 (4) | 1/59 (2) | 5/85 (6) | 4/104 (4) | 1.0 | 0.40 |
Major malformationa | 1/144 (1) | 0/59 (0) | 1/85 (1) | 0/104 (0) | 1.0 | 1.0 |
Minor malformationb | 5/144 (3) | 1/59 (2) | 4/85 (5) | 4/104 (4) | 1.0 | 0.65 |
Values are n/total N (%). P values are determined by Fisher's exact tests.
The major malformation is agenesis of the corpus callosum.
Minor malformations include arachnoid cyst, absent septal leaflets, pericallosal lipoma, and periventricular cycts in the left and right frontal lobes in the Fontan group and polymicrogyria, Chiari malformation, developmental venous anomaly in the right parietal lobe, and pineal cyst in the referent group.
Predictors of Neuropsychological and MRI Outcomes
Risk factors of selected neuropsychological test scores, after adjustment for concurrent family social status and Norwood status, are presented in Table 6. Longer total support or deep hypothermic circulatory arrest duration at first operation was significantly associated with lower scores on each of the Wechsler Intelligence Scale composites (P≤0.01 for each). Executive functions, as measured by both parent and teacher BRIEFs, was worse (ie, higher scores) in patients with ≥6 operative complications, compared with those with no complications (P=0.02 and 0.006, respectively). Scores on several end points were worse among patients who were of Hispanic ethnicity, had a possible or definite genetic abnormality, required more operations, experienced more operative complications, required more catheterizations, experienced more catheterization complications, were of younger gestational age, had an open first operation (versus shunt), had occurrence of seizure, and were younger at developmental testing.
Table 6.
Variable | Total Support Duration, min | Total DHCA Duration, min | Other Covariates |
---|---|---|---|
β Estimate±SE (P Value) | |||
Wechsler Intelligence Scales, Combineda | |||
Full‐Scale IQ | −0.09±0.03 (0.002) |
Hispanic ethnicity: −7.7±3.7 (0.04) Genetic abnormality: −6.5±2.5 (0.009) Three total operations (vs <3): −8.6±3.6 (0.02) Four or 5 total operations (vs <3): −9.1±4.2 (0.03) |
|
Verbal Comprehension | −0.07±0.03 (0.006) |
Hispanic ethnicity: −9.6±3.1 (0.003) One or 2 catheterization complications (vs 0): −1.1±2.2 (0.63) Three or more catheterization complications (vs 0): −8.6±3.5 (0.01) |
|
Perceptual Reasoning | −0.08±0.03 (0.006) |
Genetic abnormality: −6.4±2.5 (0.01) Three total operations (vs <3): −10.6±3.6 (0.004) Four or 5 total operations (vs <3): −14.3±4.2 (<0.001) |
|
Working Memory | −0.18±0.07 (0.01) | Gestational age (per week): 1.1±0.6 (0.049) | |
Processing Speed | −0.19±0.07 (0.01) | Genetic abnormality: −5.9±2.6 (0.02) | |
Wechsler Individual Achievement Test | |||
Reading Composite | −0.16±0.08 (0.04) | Seizure: −8.0±3.8 (0.04) | |
Mathematics Composite |
One operative complication at first operation (vs 0): −6.9±4.3 (0.11) Two or more operative complications at first operation (vs 0): −15.5±4.2 (<0.001) Age at developmental testing (per year): −2.1±0.6 (<0.001) |
||
Children's Memory Scale General Memory Indexb |
Birth weight (per kg): 6.2±2.9 (0.03) One to 5 operative complications (vs 0): 3.4±5.1 (0.51) Six or more operative complications (vs 0): −15.7±6.5 (0.02) One or 2 catheterization complications (vs 0): −9.0±3.8 (0.02) Three or more catheterization complications (vs 0): −8.5±5.7 (0.14) Seizure: −11.8±5.3 (0.03) |
||
Wechsler Memory Scale Compositec | −0.63±0.21 (0.006) |
One operative complication at first operation (vs 0): −16.3±5.3 (0.006) Two or more operative complications at first operation (vs 0): −14.8±5.7 (0.02) One or 2 catheterization complications (vs 0): 7.3±4.5 (0.11) Three or more catheterization complications (vs 0): −27.0±11.9 (0.03) |
|
Executive Function Summary Score | −0.01±0.004 (0.009) |
Three total operations (vs <3): −1.1±0.5 (0.03) Four or 5 total operations (vs <3): −2.0±0.6 (0.001) |
|
Behavior Rating Inventory of Executive Function | |||
Parent |
Gestational age (per week): −1.0±0.4 (0.02) Hispanic ethnicity: 8.1±3.0 (0.007) One to 5 operative complications (vs 0): 1.9±2.8 (0.50) Six or more operative complications (vs 0): 8.0±3.5 (0.02) |
||
Teacher |
Open first operation (vs shunt): 10.7±5.4 (0.0496) One to 5 operative complications (vs 0): 6.8±5.4 (0.21) Six or more operative complications (vs 0): 18.9±6.7 (0.006) |
||
Test of Visual‐Perceptual Skills Composited |
Three to 5 catheterizations (vs <3): −2.5±4.9 (0.62) Six or more catheterizations (vs <3): −18.9±5.8 (0.002) Seizure: −10.0±4.8 (0.04) |
||
Parent Conners’ ADHD Index T Score | Hispanic ethnicity: 10.1±3.3 (0.003) | ||
Reading the Mind in the Eyes Test Score | −0.02±0.01 (0.04) |
Three to 5 catheterizations (vs <3): −4.9±1.7 (0.006) Six or more catheterizations (vs <3): −7.0±1.9 (<0.001) Age at developmental testing (per year): 0.9±0.2 (<0.001) |
|
Toronto Alexithymia Scale Total Score |
Hispanic ethnicity: 5.4±2.7 (0.04) Neonatal status: 6.5±2.2 (0.004) |
||
Autism Spectrum Quotient | 0.06±0.03 (0.02) |
Genetic abnormality: 2.3±0.8 (0.007) Three total operations (vs <3): 3.8±1.2 (0.001) Four or 5 total operations (vs <3): 3.2±1.4 (0.02) |
All characteristics from Table 1 were considered for inclusion in the regression models except cardiac diagnosis, continuous age at operation, indicator for use of DHCA at first operation, NYHA functional class, and use of special services. Coefficients for intercepts, concurrent family social status, and Norwood status are not reported. Missing <10% of outcomes except for the Behavior Rating Inventory of Executive Function–Teacher (n=90), Test of Visual‐Perceptual Skills (n=93), and Reading the Mind in the Eyes (n=140) tasks. ADHD indicates attention‐deficit/hyperactivity disorder; DHCA, deep hypothermic circulatory arrest; IQ, intelligence quotient; NYHA, New York Heart Association.
Outcomes were also adjusted for type of test, either the Wechsler Intelligence Scale for Children or the Wechsler Adult Intelligence Scale.
Outcomes are based on those Fontan subjects aged <17 years (n=120).
Outcomes are based on those Fontan subjects aged ≥17 years (n=36).
Outcomes are based on those Fontan subjects aged ≥12 years (n=119).
Stepwise logistic regression analyses were conducted of 4 MRI end points (any abnormality, focal/infarction or atrophy, brain mineralization/iron deposit, any diffuse abnormality). The odds of any diffuse abnormality were associated with operative complications (P=0.009), with marginally greater odds among patients who had ≥6 operative complications compared with those with no operative complications (odds ratio=7.8, 95% CI 0.8 to 71.9, P=0.07) and significantly greater odds compared with those with 1 to 5 operative complications (odds ratio=7.0, 95% CI 1.9 to 25.9, P=0.004) after adjusting for the presence of a genetic abnormality. We did not find any statistically significant risk factors for the categories of any abnormality, focal/infarction or atrophy, or brain mineralization. The CIs for all odds ratios were wide, however, because of the small number of patients in many categories.
We also explored whether MRI findings added additional predictive ability to the models of neuropsychological test scores presented in Table 6. Focal infarction or atrophy predicted higher (worse) parent BRIEF scores (7.4±2.7, P=0.008), higher (worse) parent Conners’ ADHD/Diagnostic and Statistical Manual of Mental Disorders–Fourth Edition ADHD Index scores (8.3±3.1, P=0.008), and higher (worse) Autism Spectrum Quotient scores (2.8±1.3, P=0.03), relative to subjects without these MRI findings, respectively. The presence of brain hemosiderin/iron deposits was not a predictor of worse neurocognitive outcomes. The presence of diffuse abnormalities on anatomic MRI was not associated with any neurocognitive score, with limited power.
Discussion
In our study of adolescents who had undergone the Fontan procedure, we found that about two‐thirds (66%) had an abnormality on structural brain MRI, and 13% showed evidence of a stroke. Fontan adolescents scored significantly lower than population norms and a healthy local referent group in all of the neuropsychological domains assessed, and scores of adolescents with HLHS or other single right ventricle abnormalities who underwent the Norwood procedure were generally lower than those of adolescents who did not undergo the Norwood procedure and were significantly lower in the domains of general intelligence, reading and math achievement, and executive function. Some aspects of neuropsychological function in Fontan patients appeared to be more impaired than others. In terms of intelligence, verbal skills appeared to be stronger than perceptual reasoning skills. Processing speed, which is based on the subtests of Coding and Symbol Search, was also a relative weakness. With regard to academic achievement, substantial percentages of adolescents had reading and mathematics skills that were significantly lower than expected based on their Full‐Scale IQ scores. Fontan patients performed more poorly than referents in mnemonic function in what appeared to be a development‐dependent fashion. In terms of executive functions, parents and teachers perceived greater executive dysfunction in the adolescents than did the adolescents themselves. As many studies of children with CHD have reported, visuospatial skills were particularly weak. The frequency of parent‐reported ADHD‐related behaviors was high.
Like children with other forms of CHD,20, 21 Fontan patients manifested difficulties in social cognition, scoring worse than the referents in their ability to identify the emotions behind facial expressions (Reading the Mind in the Eyes Test) and a dimensional assessment of the ability to recognize one's own emotions (Toronto Alexithymia Scale). Compared with referents, they showed concrete, “externally‐oriented thinking” (eg, endorsing statements such as, “I prefer talking to people about their daily activities rather than their feelings” and “Looking for hidden meanings in movies or plays distracts from their enjoyment”).
Abnormalities on MRI were detected at a frequency 11‐fold higher in the Fontan patients than in the referents, with focal/multifocal abnormalities being much more common than diffuse abnormalities. Previous studies have reported that, as fetuses, patients with HLHS show reduced maturation and volumetric growth disturbances38, 39 and diffuse white matter injury.40 Preoperative brain MRI studies have shown abnormalities of myelination, cortical infolding, involution of glial cell migration bands, and presence of germinal matrix tissue,41 including periventricular leukomalacia.38 In one study, nearly three‐fourths of patients with HLHS showed new or worsened ischemic lesions (including periventricular leukomalacia) postoperatively.42 For a substantial minority (40%) of the adolescents in our cohort who showed evidence of a stroke, this finding had not been previously reported, highlighting that its occurrence can be clinically silent.
Among those who underwent genetic evaluation and testing with chromosomal microarray, 7% had a pathogenic finding. There is limited information about the diagnostic yield of chromosomal microarray in CHD. De novo CNVs have been reported in HLHS.43 Of the previously published loci thought to confer a significant risk for CHD,44, 45, 46 3 members of our cohort had overlapping CNVs: a 15q11.2 deletion previously reported in 12 cases with CHD,44 a 2q13 duplication,47 and a 4q35.1 terminal deletion previously associated with CHD.48 The remaining 3 CNVs were not previously described, but unaffected parents were tested and all 3 were de novo rare CNVs (3q28 deletion, 7q36.3 deletion, and 9q31.2 duplication). Our 5% (7/134) pathogenic CNV detection rate for loci with significant risk for CHD is at the lower end of published estimates of 5% to 10%.44, 46, 47, 48, 49, 50 This is most likely because of the relatively high number of variants of unknown significance for which parent samples were not available to determine de novo status and a more complete assessment for pathogenicity.
Our study should be viewed in light of its limitations. The cross‐sectional design required retrospective record review of medical history. Further, some patients did not have their surgeries or catheterizations performed at our institution, limiting the comprehensiveness of medical information available to us. In particular, the total number of hospital admissions or total lengths of stays across admissions as a measure of global morbidity could not be analyzed. Approximately half of potential subjects who were eligible for this study were either followed elsewhere and lost to our follow‐up or declined participation; participants may have been biased toward either better or worse outcomes than the general Fontan population. Although all subjects were invited to participate in the genetic arm of the study, only 87% chose to do so. Moreover, known single gene point mutations, an established cause of syndromic and nonsyndromic CHD, would not be detected by array comparative genomic hybridization. We did not adjust for multiple testing and many variables were collinear in this exploratory analysis. In addition, we did not validate our risk factor analysis in an independent sample. Finally, anatomic brain MRI findings in Fontan patients were compared with those in optimal referents without known risk factors for brain injury. Anatomic brain MRI is relatively insensitive for delineating subtle central nervous system injury, and further reports describing abnormalities of brain structure, microstructure, and function in this cohort are in process.
In summary, we found that abnormalities of neuropsychological performance in patients who have undergone the Fontan procedure are common and generally more severe than those of children with 2‐ventricle congenital heart defects. Moreover, larger SDs of the scores in Fontan patients, compared with those of the referents, indicate great variability of outcomes within the Fontan population. The neurodevelopmental deficits and high frequency of structural brain and genetic abnormalities in the Fontan cohort highlight the need for continued research on interventions to improve long‐term outcomes in this high‐risk group.
Sources of Funding
This work was supported by R01 HL096825 from the National Heart, Lung, and Blood Institute, the Farb Family Fund, and the Kostin Family Innovation Fund. This work is solely the responsibility of the authors and does not necessarily represent the official views of the National Heart, Lung, and Blood Institute or the National Institutes of Health.
Disclosures
None.
(J Am Heart Assoc. 2015;4:e002302 doi: 10.1161/JAHA.115.002302)
References
- 1. Atallah J, Dinu IA, Joffe AR, Robertson CM, Sauve RS, Dyck JD, Ross DB, Rebeyka IM. Two‐year survival and mental and psychomotor outcomes after the Norwood procedure: an analysis of the modified Blalock‐Taussig shunt and right ventricle‐to‐pulmonary artery shunt surgical eras. Circulation. 2008;118:1410–1418. [DOI] [PubMed] [Google Scholar]
- 2. Sistino JJ, Bonilha HS. Improvements in survival and neurodevelopmental outcomes in surgical treatment of hypoplastic left heart syndrome: a meta‐analytic review. J Extra Corpor Technol. 2012;44:216–223. [PMC free article] [PubMed] [Google Scholar]
- 3. Williams IA, Fifer C, Jaeggi E, Levine JC, Michelfelder EC, Szwast AL. The association of fetal cerebrovascular resistance with early neurodevelopment in single ventricle congenital heart disease. Am Heart J. 2013;165:544–550.e1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Sarajuuri A, Jokinen E, Puosi R, Mildh L, Mattila I, Lano A, Lonnqvist T. Neurodevelopment in children with hypoplastic left heart syndrome. J Pediatr. 2010;157:414–420, 20.e1‐e4. [DOI] [PubMed] [Google Scholar]
- 5. Forbess JM, Visconti KJ, Hancock‐Friesen C, Howe RC, Bellinger DC, Jonas RA. Neurodevelopmental outcome after congenital heart surgery: results from an institutional registry. Circulation. 2002;106:I95–I102. [PubMed] [Google Scholar]
- 6. McCrindle BW, Williams RV, Mitchell PD, Hsu DT, Paridon SM, Atz AM, Li JS, Newburger JW. Relationship of patient and medical characteristics to health status in children and adolescents after the Fontan procedure. Circulation. 2006;113:1123–1129. [DOI] [PubMed] [Google Scholar]
- 7. Longmuir PE, Banks L, McCrindle BW. Cross‐sectional study of motor development among children after the Fontan procedure. Cardiol Young. 2012;22:443–450. [DOI] [PubMed] [Google Scholar]
- 8. Mahle WT, Clancy RR, Moss EM, Gerdes M, Jobes DR, Wernovsky G. Neurodevelopmental outcome and lifestyle assessment in school‐aged and adolescent children with hypoplastic left heart syndrome. Pediatrics. 2000;105:1082–1089. [DOI] [PubMed] [Google Scholar]
- 9. Idorn L, Jensen AS, Juul K, Overgaard D, Nielsen NP, Sorensen K, Reimers JI, Sondergaard L. Quality of life and cognitive function in Fontan patients, a population‐based study. Int J Cardiol. 2013;168:3230–3235. [DOI] [PubMed] [Google Scholar]
- 10. Sugimoto A, Ota N, Ibuki K, Miyakoshi C, Murata M, Tosaka Y, Yamazaki T, Sakamoto K. Risk factors for adverse neurocognitive outcomes in school‐aged patients after the Fontan operation. Eur J Cardiothorac Surg. 2013;44:454–461. [DOI] [PubMed] [Google Scholar]
- 11. Newburger JW, Sleeper LA, Bellinger DC, Goldberg CS, Tabbutt S, Lu M, Mussatto KA, Williams IA, Gustafson KE, Mital S, Pike N, Sood E, Mahle WT, Cooper DS, Dunbar‐Masterson C, Krawczeski CD, Lewis A, Menon SC, Pemberton VL, Ravishankar C, Atz TW, Ohye RG, Gaynor JW. Early developmental outcome in children with hypoplastic left heart syndrome and related anomalies: the single ventricle reconstruction trial. Circulation. 2012;125:2081–2091. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Goldberg CS, Schwartz EM, Brunberg JA, Mosca RS, Bove EL, Schork MA, Stetz SP, Cheatham JP, Kulik TJ. Neurodevelopmental outcome of patients after the Fontan operation: a comparison between children with hypoplastic left heart syndrome and other functional single ventricle lesions. J Pediatr. 2000;137:646–652. [DOI] [PubMed] [Google Scholar]
- 13. Uzark K, Lincoln A, Lamberti JJ, Mainwaring RD, Spicer RL, Moore JW. Neurodevelopmental outcomes in children with Fontan repair of functional single ventricle. Pediatrics. 1998;101:630–633. [DOI] [PubMed] [Google Scholar]
- 14. Wernovsky G, Stiles KM, Gauvreau K, Gentles TL, du Plessis AJ, Bellinger DC, Walsh AZ, Burnett J, Jonas RA, Mayer JE Jr, Newburger JW. Cognitive development after the Fontan operation. Circulation. 2000;102:883–889. [DOI] [PubMed] [Google Scholar]
- 15. Goldberg CS, Mussatto K, Licht D, Wernovsky G. Neurodevelopment and quality of life for children with hypoplastic left heart syndrome: current knowns and unknowns. Cardiol Young. 2011;21(suppl 2):88–92. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Rajantie I, Laurila M, Pollari K, Lonnqvist T, Sarajuuri A, Jokinen E, Malkia E. Motor development of infants with univentricular heart at the ages of 16 and 52 weeks. Pediatr Phys Ther. 2013;25:444–450. [DOI] [PubMed] [Google Scholar]
- 17. Sarajuuri A, Jokinen E, Mildh L, Tujulin AM, Mattila I, Valanne L, Lonnqvist T. Neurodevelopmental burden at age 5 years in patients with univentricular heart. Pediatrics. 2012;130:e1636–e1646. [DOI] [PubMed] [Google Scholar]
- 18. Puosi R, Korkman M, Sarajuuri A, Jokinen E, Mildh L, Mattila I, Lonnqvist T. Neurocognitive development and behavioral outcome of 2‐year‐old children with univentricular heart. J Int Neuropsychol Soc. 2011;17:1094–1103. [DOI] [PubMed] [Google Scholar]
- 19. Gaynor JW, Ittenbach RF, Gerdes M, Bernbaum J, Clancy RR, McDonald‐McGinn DM, Zackai EH, Wernovsky G, Nicolson SC, Spray TL. Neurodevelopmental outcomes in preschool survivors of the Fontan procedure. J Thorac Cardiovasc Surg. 2014;147:1276–1282. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Bellinger DC, Wypij D, Rivkin MJ, DeMaso DR, Robertson RL Jr, Dunbar‐Masterson C, Rappaport LA, Wernovsky G, Jonas RA, Newburger JW. Adolescents with d‐transposition of the great arteries corrected with the arterial switch procedure: neuropsychological assessment and structural brain imaging. Circulation. 2011;124:1361–1369. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Bellinger DC, Rivkin MJ, Demaso D, Robertson RL, Stopp C, Dunbar‐Masterson C, Wypij D, Newburger JW. Adolescents with tetralogy of Fallot: neuropsychological assessment and structural brain imaging. Cardiol Young. 2015;25:338–347. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22. Evans AC, The NIH. MRI study of normal brain development. Neuroimage. 2006;30:184–202. [DOI] [PubMed] [Google Scholar]
- 23. Wechsler D. WISC‐IV Administration and Scoring Manual. San Antonio, TX: The Psychological Corporation; 2003. [Google Scholar]
- 24. Wechsler D. WAIS‐IV Administration and Scoring Manual. San Antonio, TX: NCS Pearson Inc; 2008. [Google Scholar]
- 25. The Psychological Corporation . Wechsler Individual Achievement Test‐Second Edition. San Antonio, TX: The Psychological Corporation; 2002. [Google Scholar]
- 26. Cohen MJ. Children's Memory Scale. San Antonio, TX: The Psychological Corporation; 1997. [Google Scholar]
- 27. Wechsler D. WMS‐IV. Administration and Scoring Manual. San Antonio, TX: NCS Pearson Inc; 2009. [Google Scholar]
- 28. Delis DC, Kaplan B, Kramer JH. Delis‐Kaplan Executive Function System. San Antonio, TX: The Psychological Corporation; 2001. [Google Scholar]
- 29. Gioia GA, Isquith PK, Guy SC, Kenworthy L. Behavior Rating Inventory of Executive Function. Odessa, FL: Psychological Assessment Resources Inc; 2000. [Google Scholar]
- 30. Guy SC, Isquith PK, Gioia GA. Behavior Rating Inventory of Executive Function. Self‐Report Version. Odessa, FL: Psychological Assessment Resources Inc; 2004. [Google Scholar]
- 31. Gardner MF. Test of Visual‐Perceptual Skills (Non‐Motor) (Upper Level) Revised. Hydesville, CA: Psychological and Educational Publications Inc; 1997. [Google Scholar]
- 32. Bernstein JH, Waber DP. Developmental Scoring System for the Rey‐Osterrieth Complex Figure. Odessa, FL: Psychological Assessment Resources Inc; 1986. [Google Scholar]
- 33. Hegarty M, Richardson AE, Montello DR, Lovelace K, Subbiah I. Development of a self‐report measure of environmental spatial ability. Intelligence. 2002;30:425–447. [Google Scholar]
- 34. Conners CK. Conners’ Rating Scales‐Revised. North Tonawanda, NY: Multi‐Health Systems Inc; 2001. [Google Scholar]
- 35. Baron‐Cohen S, Wheelwright S, Hill J, Raste Y, Plumb I. The, “Reading the Mind in the Eyes” Test revised version: a study with normal adults, and adults with Asperger syndrome or high‐functioning autism. J Child Psychol Psychiatry. 2001;42:241–251. [PubMed] [Google Scholar]
- 36. Bagby RM, Parker JD, Taylor GJ. The twenty‐item Toronto Alexithymia Scale–I. Item selection and cross‐validation of the factor structure. J Psychosom Res. 1994;38:23–32. [DOI] [PubMed] [Google Scholar]
- 37. Baron‐Cohen S, Wheelwright S, Skinner R, Martin J, Clubley E. The autism‐spectrum quotient (AQ): evidence from Asperger syndrome/high‐functioning autism, males and females, scientists and mathematicians. J Autism Dev Disord. 2001;31:5–17. [DOI] [PubMed] [Google Scholar]
- 38. Goff DA, Shera DM, Tang S, Lavin NA, Durning SM, Nicolson SC, Montenegro LM, Rome JJ, Gaynor JW, Spray TL, Vossough A, Licht DJ. Risk factors for preoperative periventricular leukomalacia in term neonates with hypoplastic left heart syndrome are patient related. J Thorac Cardiovasc Surg. 2014;147:1312–1318. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39. Clouchoux C, du Plessis AJ, Bouyssi‐Kobar M, Tworetzky W, McElhinney DB, Brown DW, Gholipour A, Kudelski D, Warfield SK, McCarter RJ, Robertson RL Jr, Evans AC, Newburger JW, Limperopoulos C. Delayed cortical development in fetuses with complex congenital heart disease. Cereb Cortex. 2013;23:2932–2943. [DOI] [PubMed] [Google Scholar]
- 40. Hinton RB, Andelfinger G, Sekar P, Hinton AC, Gendron RL, Michelfelder EC, Robitaille Y, Benson DW. Prenatal head growth and white matter injury in hypoplastic left heart syndrome. Pediatr Res. 2008;64:364–369. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41. Licht DJ, Shera DM, Clancy RR, Wernovsky G, Montenegro LM, Nicolson SC, Zimmerman RA, Spray TL, Gaynor JW, Vossough A. Brain maturation is delayed in infants with complex congenital heart defects. J Thorac Cardiovasc Surg. 2009;137:529–536. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42. Dent CL, Spaeth JP, Jones BV, Schwartz SM, Glauser TA, Hallinan B, Pearl JM, Khoury PR, Kurth CD. Brain magnetic resonance imaging abnormalities after the Norwood procedure using regional cerebral perfusion. J Thorac Cardiovasc Surg. 2005;130:1523–1530. [DOI] [PubMed] [Google Scholar]
- 43. Payne AR, Chang SW, Koenig SN, Zinn AR, Garg V. Submicroscopic chromosomal copy number variations identified in children with hypoplastic left heart syndrome. Pediatr Cardiol. 2012;33:757–763. [DOI] [PubMed] [Google Scholar]
- 44. Soemedi R, Topf A, Wilson IJ, Darlay R, Rahman T, Glen E, Hall D, Huang N, Bentham J, Bhattacharya S, Cosgrove C, Brook JD, Granados‐Riveron J, Setchfield K, Bu'lock F, Thornborough C, Devriendt K, Breckpot J, Hofbeck M, Lathrop M, Rauch A, Blue GM, Winlaw DS, Hurles M, Santibanez‐Koref M, Cordell HJ, Goodship JA, Keavney BD. Phenotype‐specific effect of chromosome 1q21.1 rearrangements and GJA5 duplications in 2436 congenital heart disease patients and 6760 controls. Hum Mol Genet. 2012;21:1513–1520. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45. Greenway SC, Pereira AC, Lin JC, DePalma SR, Israel SJ, Mesquita SM, Ergul E, Conta JH, Korn JM, McCarroll SA, Gorham JM, Gabriel S, Altshuler DM, Quintanilla‐Dieck Mde L, Artunduaga MA, Eavey RD, Plenge RM, Shadick NA, Weinblatt ME, De Jager PL, Hafler DA, Breitbart RE, Seidman JG, Seidman CE. De novo copy number variants identify new genes and loci in isolated sporadic tetralogy of Fallot. Nat Genet. 2009;41:931–935. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46. Fahed AC, Gelb BD, Seidman JG, Seidman CE. Genetics of congenital heart disease: the glass half empty. Circ Res. 2013;112:707–720. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47. Carey AS, Liang L, Edwards J, Brandt T, Mei H, Sharp AJ, Hsu DT, Newburger JW, Ohye RG, Chung WK, Russell MW, Rosenfeld JA, Shaffer LG, Parides MK, Edelmann L, Gelb BD. Effect of copy number variants on outcomes for infants with single ventricle heart defects. Circ Cardiovasc Genet. 2013;6:444–451. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48. Silversides CK, Lionel AC, Costain G, Merico D, Migita O, Liu B, Yuen T, Rickaby J, Thiruvahindrapuram B, Marshall CR, Scherer SW, Bassett AS. Rare copy number variations in adults with tetralogy of Fallot implicate novel risk gene pathways. PLoS Genet. 2012;8:e1002843. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49. Hitz MP, Lemieux‐Perreault LP, Marshall C, Feroz‐Zada Y, Davies R, Yang SW, Lionel AC, D'Amours G, Lemyre E, Cullum R, Bigras JL, Thibeault M, Chetaille P, Montpetit A, Khairy P, Overduin B, Klaassen S, Hoodless P, Awadalla P, Hussin J, Idaghdour Y, Nemer M, Stewart AF, Boerkoel C, Scherer SW, Richter A, Dube MP, Andelfinger G. Rare copy number variants contribute to congenital left‐sided heart disease. PLoS Genet. 2012;8:e1002903. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50. Erdogan F, Larsen LA, Zhang L, Tumer Z, Tommerup N, Chen W, Jacobsen JR, Schubert M, Jurkatis J, Tzschach A, Ropers HH, Ullmann R. High frequency of submicroscopic genomic aberrations detected by tiling path array comparative genome hybridisation in patients with isolated congenital heart disease. J Med Genet. 2008;45:704–709. [DOI] [PubMed] [Google Scholar]